NANETS in collaboration with the Society of Nuclear Medicine and Molecular Imaging presents:
PRRT: Background, Published Results, Patient Selection Details, Sequencing of Therapy, and Future Directions

July 23, 2020, 6:00 pm - 7:00 pm ET

bodie and strosberg

Presenters:
Lisa Bodei, MD, Memorial Sloan Kettering Cancer Center
Jonathan Strosberg, MD, Moffitt Cancer Center

Learning Objectives:

  • Understand the regulatory considerations for the administration of 177Lu-DOTATATE
  • Appreciate the logistical considerations and space planning for treatment
  • Understand the adjunctive medication options and their appropriate utilization
  • Understand where 177Lutetium-dotatate might fit within the neuroendocrine tumor treatment landscape
  • Understand impact of PRRT on key endpoints including progression-free survival and health-related quality of life
  • Identify potential risks of 177Lutetium-dotatate, including long-term myelotoxicity

Accreditation
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education through the joint providership of CMEsolutions and North American Neuroendocrine Tumor Society. The CMEsolutions is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The CMEsolutions designates this enduring activity for a maximum of 1 AMA PRA Category 1 Credits™, MOC and nursing continued education credits

Register - Here

 

NANETS Webinar Series:
Hereditary Syndromes with NETs: MEN1/2, VHL Pheochromocytoma /Paraganglioma

September 16, 2020 - Date Subject to Change

Presenters:
Lauren Fishbein, MD, PhD, University of Colorado School of Medicine
Mark Lewis, MD, Intermountain Healthcare

Learning Objectives:

  • Analyze the strengths and weaknesses of imaging modalities in identifying NETs
  • Recognize the relationships between genetics, immunochemistry and NETs. Identify the goals and role of surgery in the treatment and management of NETs
  • Examine the various symptom and medical management therapies of NETs
  • Illustrate the challenges in diagnosing and managing NETs
  • Apply a multidisciplinary approach to the management of NETs

Accreditation
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education through the joint providership of CMEsolutions and North American Neuroendocrine Tumor Society. The CMEsolutions is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The CMEsolutions designates this enduring activity for a maximum of 1 2 AMA PRA Category 1 Credits™, MOC and nursing continued education credits 

Registration - to be posted four weeks in advance 

NANETS Webinar Series:
Medical Management: Lung NETs

November 18, 2020 - Date Subject to Change

Presenters:
Sukhmani Padda, MD, Stanford University
Robert Ramirez, MD, Ochsner Medical Center

Learning Objectives:

  • Analyze the strengths and weaknesses of imaging modalities in identifying Lung NETs
  • Examine the various symptom and medical management therapies of Lung NETs
  • Illustrate the challenges in diagnosing and managing Lung NETs
  • Apply a multidisciplinary approach to the management of Lung NETs

Accreditation
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education through the joint providership of CMEsolutions and North American Neuroendocrine Tumor Society. The CMEsolutions is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The CMEsolutions designates this enduring activity for a maximum of 1 AMA PRA Category 1 Credits.™  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Registration - to be posted four weeks in advance 

NANETS Webinar Series:
Surgical Management of Pancreatic Neuroendocrine Tumors
in collaboration with the Society of Surgical Oncology 

Part I and Part II: Members of NANETS can watch the recording of part-one by logging in here

Presenters:
James Howe, MD, Carver College of Medicine, University of Iowa
Rodney Pommier, MD, Oregon Health & Science University Hospital

Moderators:
Jennifer Eads, MD, University of Pennsylvania (Part I)
Jennifer Chan, MD, Dana Farber Cancer Institute (Part II)

2 AMA PRA Category 1 Credits™, MOC and nursing continued education credits (must attend both webinars to obtain credits)

NANETS, in collaboration with the Society of Surgical Oncology (SSO), presents a two-part webinar on the published Consensus Paper on the Surgical Management of Pancreatic Neuroendocrine Tumors (pNETs). 

Due to the rarity of these tumors, institutional experiences may be quite variable, and clinicians must rely upon their judgment and discussions in multidisciplinary tumor boards to best serve their patients. During this webinar, we will identify several areas related to the surgical management of patients with pNETs and will explore options for dealing with important clinical questions.

Click Here for the Consensus Paper 

Accreditation
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education through the joint providership of CMEsolutions and North American Neuroendocrine Tumor Society. The CMEsolutions is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The CMEsolutions designates this enduring activity for a maximum of 2 AMA PRA Category 1 Credits.™  Physicians should claim only the credit commensurate with the extent of their participation in the activity.